Clinical trial
Comparative Study Between Topical Crisaborole 2% and Topical Fluticasone Propionate 0.05% in Treatment of Patients With Mild to Moderate Atopic Dermatitis
NCT07537751 is registered in ClinicalTrials.gov with Noura Abdelmoneim Mohammed Elseessy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study Between Topical Crisaborole 2% and Topical Fluticasone Propionate 0.05% in Treatment of Patients With Mild to Moderate Atopic Dermatitis
- Lead sponsor
- Noura Abdelmoneim Mohammed Elseessy
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2024
- Completion date
- March 1, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis, eczema